雌二醇對去卵巢大鼠骨和生殖系統(tǒng)損傷的修復作用
[Abstract]:In postmenopausal women, due to the decrease of ovarian function, the level of estrogen plummeted, the bone turnover rate in vivo was significantly accelerated, the rate of bone resorption exceeded the rate of bone formation, resulting in bone mass loss and decreased bone mineral density. Osteoporosis caused by increased bone fragility is called postmenopausal osteoporosis (postmenopausal osteoporosis,PMOP). With the sharp decrease of estrogen secretion and accelerated bone loss in postmenopausal women, PMOP has become a high incidence disease which seriously endangers social and public health, and is also a hot and difficult point in international bone disease research. The purpose of this study was to observe the effects of estrogen on bone tissue, uterus and vaginal structure injury in postmenopausal osteoporosis rats, and the effect of estrogen on mastocyte proliferation in bone tissue of osteoporotic rats. To investigate the repair effect of estrogen on bone tissue and reproductive system injury in osteoporotic rats and the possibility of mast cells as the basis for the diagnosis and treatment of postmenopausal osteoporosis. In this study, 3-month-old SD rats were used to establish the rat model of postmenopausal osteoporosis, and then Estradiol was injected intraperitoneally for therapeutic administration. After administration, the rats were killed after cervical dislocated. The indexes of each organ were calculated. The content of serum calcium (Ca) was measured by flame atomic absorption spectrometry, and the levels of estrogen (E2) and alkaline phosphatase (ALP) in serum were measured by ELISA method. Paraffin sections were made after fixation and decalcification of femur, tibia and femoral head. HE staining and toluidine blue staining were performed. Morphometric analysis was carried out by Image-Pro Plus image analysis system, and the number of mastocytes in bone tissue was counted microscopically. The pathological changes of uterus and vagina were observed by HE staining after routine paraffin sections of uterus and vagina, and morphometric analysis was carried out. The results showed that serum Ca, E2, ALP and uterine index in ovariectomy group were significantly lower than those in pseudo-operation group (P 0.05), P < 0.01, P 0.01, P < 0.01, respectively. The percentage of bone trabecular area and the thickness of bone cerebellum in ovariectomy group were significantly lower than those in false operation group (P 0.01), and the distance between bone trabeculae was increased (P 0.01). Compared with the pseudo-operation group, the number of mastocytes in the cross section of the femur and femoral head in the ovariectomy group was significantly increased (P 0.01), the thickness of uterine canal diameter was decreased (P 0.01), the thickness of uterine mucous membrane and the number of uterine gland were decreased (P 0.05), and the thickness of uterine canal diameter was decreased (P < 0.01). The thickness of vaginal mucosa and the number of vessels in muscle layer decreased (P 0.01), the number of vessels in lamina propria decreased (P 0.05), and the above symptoms were relieved after treatment with estridiol. The conclusions are as follows: 3 months old SD rats can successfully establish postmenopausal osteoporosis model 3 months after ovariectomy. Intermittent intraperitoneal injection of estrogen can effectively improve the biochemical indexes of bone metabolism and bone tissue microstructure in ovariectomy osteoporosis rats, and has the effect of preventing and treating postmenopausal osteoporosis. Estradiol can effectively inhibit the proliferation of bone hypertrophic cells in ovariectomy osteoporosis rats, and bone hypertrophic cells are expected to be the basis for the diagnosis and treatment of postmenopausal osteoporosis. Estradiol can effectively alleviate the atrophy of uterus and vagina in ovariectomy osteoporosis rats and repair the reproductive system injury in postmenopausal osteoporosis rats.
【學位授予單位】:陜西理工大學
【學位級別】:碩士
【學位授予年份】:2017
【分類號】:R580
【參考文獻】
相關期刊論文 前10條
1 辛薇;祁珊珊;曾海濤;;雌激素對去卵巢骨質疏松大鼠子宮組織形態(tài)的影響[J];黑龍江畜牧獸醫(yī);2016年15期
2 鄭紅星;祁珊珊;曾海濤;;葛根異黃酮聯(lián)合VitD_3對去卵巢骨質疏松大鼠骨組織構造的影響[J];中國骨質疏松雜志;2016年07期
3 趙雨坤;鄭康;郭晴晴;樊丹平;何小鵑;呂愛平;;一種基于EDTA脫鈣法的改良骨組織脫鈣方法[J];中國實驗方劑學雜志;2016年11期
4 祁珊珊;王永吉;辛薇;;SD大鼠絕經后骨質疏松疾病動物模型的構建[J];臨床與實驗病理學雜志;2016年01期
5 祁珊珊;王永吉;龐田田;楊yN琦;吳婕;辛薇;;去卵巢大鼠骨、生殖系統(tǒng)組織病理學與形態(tài)計量學觀察[J];中國骨質疏松雜志;2015年07期
6 姚國榮;;雌二醇和孕酮對雙側卵巢切除小鼠子宮局部巨噬細胞及M-CSF表達的影響研究[J];中國現(xiàn)代醫(yī)生;2015年18期
7 祁珊珊;楊yN琦;龐田田;王永吉;;去卵巢法建立SD大鼠絕經后骨質疏松模型手術探討[J];中國獸醫(yī)雜志;2014年02期
8 鄺志強;張榮華;;運動聯(lián)合阿侖膦酸鈉片對去卵巢大鼠RANKL/OPG平衡及MAPK信號通路的影響[J];第二軍醫(yī)大學學報;2013年08期
9 孫東霞;;絕經后骨質疏松癥患者綜合治療前后生活質量分析[J];內蒙古醫(yī)學雜志;2011年S8期
10 鄭家三;夏成;朱玉哲;張洪友;徐闖;;日糧能量水平對奶牛繁殖性能、血漿代謝產物和生殖激素的影響[J];中國奶牛;2011年10期
相關博士學位論文 前1條
1 耿文鑫;抗絕經后骨質疏松蛋白疫苗的實驗研究[D];西北大學;2013年
,本文編號:2494961
本文鏈接:http://sikaile.net/yixuelunwen/nfm/2494961.html